Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Mifepristone

EU orphan designation number: EU/3/05/298   
Active ingredient: Mifepristone
Indication: Treatment of Cushing’s syndrome secondary to ectopic ACTH secretion
Sponsor: Laboratoire HRA Pharma
15 rue Béranger, F-75003 Paris, France

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
16/08/2005 Orphan Designation EMEA/OD/022/05 (2005)2945 of 27/07/2005
25/08/2005 Change of address of sponsor